Latest News about GMAB
Recent news which mentions GMAB
3 Things About BioNTech That Smart Investors Know
April 29, 2022
From Motley Fool
From Benzinga
From Benzinga
BioNTech And Matinas BioPharma Announce Exclusive Research Collaboration To Evaluate Novel Delivery Technology For mRNA-based Vaccines
April 11, 2022
From Benzinga
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022
January 31, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021
December 01, 2021
From Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
November 05, 2021
From Benzinga
From Benzinga
Why Genmab's Stock Is Trading Higher Today
September 21, 2021
From Benzinga
Why Seagen's Stock Is Trading Higher Today
September 21, 2021
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
FDA Gives Accelerated Approval to Seagen - Genmab's ADC In Cervical Cancer
September 21, 2021
From Benzinga
Seagen, Genmab Present Tisotumab Vedotin Combo Data In Cervical Cancer
September 20, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021
September 16, 2021
From Benzinga
Moderna stock extends rally after price target gets a 77% boost at Morgan Stanley
September 07, 2021
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021
September 07, 2021
From Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2021
August 24, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Friday
August 20, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.